In the DES group , the @-year EFS was @ % vs. @ % ( p = @ ) , freedom from TLR was @ % vs. @ % ( p = @ ) , primary patency was @ % vs. @ % ( p = @ ) , and clinical benefit was sustained in @ % vs. @ % of patients ( p = @ ) in the Japanese and non-Japanese cohorts , respectively .